Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK598809 and intravenous ethanol interaction study in healthy volunteers
NL-OMON32561Active, not recruiting
- Sponsor
- GSK
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of GSK598809 and ethanol in alcohol use disorder (AUD) and substance use disorder (SUD) (4 arms), sponsored by GSK. Primary endpoints: Safety and tolerability, Breath ethanol concentrations and 7 more. Started Sep 2008; status: active, not recruiting.
02
Drugs
GSK598809ethanol
03
Conditions
alcohol use disorder (AUD)substance use disorder (SUD)
Beyond the preview
Go deeper on NL-OMON32561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32561.